Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of SYH2066 Tablets in Adult Participants With Respiratory Syncytial Virus Infection.
NCT07881991 is registered in ClinicalTrials.gov with CSPC Ouyi Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profile of SYH2066 Tablets in Adult Participants With Respiratory Syncytial Virus Infection.
- Lead sponsor
- CSPC Ouyi Pharmaceutical Co., Ltd.
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- November 13, 2026
- Completion date
- March 31, 2028
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.